BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11466689)

  • 1. Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan.
    Tajiri T; Suita S; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Handa N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M;
    Cancer; 2001 Jul; 92(2):349-53. PubMed ID: 11466689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One hundred neuroblastomas detected through a mass screening system in Japan.
    Hachitanda Y; Ishimoto K; Hata J; Shimada H
    Cancer; 1994 Dec; 74(12):3223-6. PubMed ID: 7982186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into infant neuroblastomas based on an analysis of neuroblastomas detected by mass screening at 6 months of age in Japan.
    Suita S; Tajiri T; Higashi M; Tanaka S; Kinoshita Y; Takahashi Y; Tatsuta K
    Eur J Pediatr Surg; 2007 Feb; 17(1):23-8. PubMed ID: 17407017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characteristics of mediastinal neuroblastoma.
    Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Tasaka H; Yano H; Akiyama H; Ikeda K
    Eur J Pediatr Surg; 2000 Dec; 10(6):353-9. PubMed ID: 11215774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unfavorable DNA ploidy and Ha-ras p21 findings in neuroblastomas detected through mass screening.
    Kusafuka T; Nagahara N; Oue T; Imura K; Nakamura T; Kobayashi Y; Komoto Y; Fukuzawa M; Okada A; Nakayama M
    Cancer; 1995 Aug; 76(4):695-9. PubMed ID: 8625168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
    Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
    J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: a case report including the biologic and phenotypic characteristics of the cell line.
    Hiraiwa H; Hamazaki M; Takata A; Kikuchi H; Hata J
    Cancer; 1997 May; 79(10):2036-44. PubMed ID: 9149033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
    Takeuchi LA; Hachitanda Y; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD
    Cancer; 1995 Dec; 76(11):2363-71. PubMed ID: 8635044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
    Matthay KK; Perez C; Seeger RC; Brodeur GM; Shimada H; Atkinson JB; Black CT; Gerbing R; Haase GM; Stram DO; Swift P; Lukens JN
    J Clin Oncol; 1998 Apr; 16(4):1256-64. PubMed ID: 9552023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different characteristics of neuroblastomas in cases found by mass screening and non-screening: evaluation of mass screening for neuroblastoma in Kitakyushu City.
    Ariyoshi N
    J UOEH; 1993 Dec; 15(4):251-66. PubMed ID: 8265887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features and outcome of neuroblastoma detected before birth.
    Granata C; Fagnani AM; Gambini C; Boglino C; Bagnulo S; Cecchetto G; Federici S; Inserra A; Michelazzi A; Riccipetitoni G; Rizzo A; Tamaro P; Jasonni V; De Bernardi B
    J Pediatr Surg; 2000 Jan; 35(1):88-91. PubMed ID: 10646781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
    Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
    Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery.
    Kushner BH; Wolden S; LaQuaglia MP; Kramer K; Verbel D; Heller G; Cheung NK
    J Clin Oncol; 2001 Jun; 19(11):2821-8. PubMed ID: 11387353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute.
    Nishio N; Mimaya J; Nara T; Takashima Y; Horikoshi Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
    Pediatr Int; 2006 Dec; 48(6):531-5. PubMed ID: 17168969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifocal neuroblastoma: biologic behavior and surgical aspects.
    Hiyama E; Yokoyama T; Hiyama K; Yamaoka H; Matsuura Y; Nishimura Si; Ueda K
    Cancer; 2000 Apr; 88(8):1955-63. PubMed ID: 10760774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.